The findings underscore the importance of proximal proteomics analysis in revealing ALK signaling networks, and these novel ALK interactors as potential therapeutic targets in ALK-driven NBs remain to be explored in future. This evidence concerns the gene ALK and Nijmegen breakage syndrome.